News and Media Alivio to receive up to $14.75 million in upfront and near‐term license exercise payments and is eligible to receive royalties on product sales and over $260 million in research and development milestones STAMFORD, Conn. and BOSTON – Jan 28, 2019 —...
News and Media Partners to research novel targets for reductions in pain STAMFORD, Conn., and BEDFORD, Mass., January 7, 2019 – Purdue Pharma L.P. and Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and...